Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mona Marabani"'
Autor:
Alla Melman, Min Jiat Teng, Danielle M Coombs, Qiang Li, Laurent Billot, Thomas Lung, Eileen Rogan, Mona Marabani, Owen Hutchings, Chris G Maher, Gustavo C Machado
Publikováno v:
JMIR Research Protocols, Vol 13, p e60298 (2024)
Externí odkaz:
https://doaj.org/article/05fd50d34eb34e4aa2fbd34c02ee0a3f
Autor:
Alla Melman, Min Jiat Teng, Danielle M Coombs, Qiang Li, Laurent Billot, Thomas Lung, Eileen Rogan, Mona Marabani, Owen Hutchings, Chris G Maher, Gustavo C Machado
Publikováno v:
JMIR Research Protocols, Vol 13, p e50146 (2024)
BackgroundLow back pain (LBP) was the fifth most common reason for an emergency department (ED) visit in 2020-2021 in Australia, with >145,000 presentations. A total of one-third of these patients were subsequently admitted to the hospital. The admit
Externí odkaz:
https://doaj.org/article/b6bbc29e93474731bea25b16e7b054e5
Publikováno v:
International Journal of Rheumatic Diseases. 24:3-14
The last decade has seen considerable advancement in the treatment options available to patients with rheumatoid arthritis (RA) through the development of oral, small molecules that target and inhibit Janus kinases (JAKi). These drugs have a rapid on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcbec4e47e4b7ead3d39e02f1e554844
https://doi.org/10.1111/1756-185x.14127
https://doi.org/10.1111/1756-185x.14127
Autor:
Freddy Faccin, Brian G. Feagan, Mona Marabani, Jashin J Wu, Gilberto Castañeda-Hernández, Claire Spronk
Publikováno v:
Advances in Therapy. 37:4491-4518
With the increasing availability of biosimilars, the practice of switching therapies for non-medical reasons between an originator biologic and an analogous biosimilar has become more common. The evidence to support this practice mostly comes from si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b30b538649eeb416b72524c35847ca90
https://doi.org/10.1007/s12325-020-01472-1
https://doi.org/10.1007/s12325-020-01472-1
Autor:
Winston Liauw, Matthew C. Cook, Ross A. McKinnon, Mona Marabani, Nicolle H. Packer, Ian C. Marschner, Johannes B. Prins
Publikováno v:
Biodrugs
Background The efficacy, safety and immunogenicity risk of switching between an originator biologic and a biosimilar or from one biosimilar to another are of potential concern. Objectives The aim was to conduct a systematic literature review of the o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d609f57f7cc7cdaf6f33a12b00d54b98
https://doi.org/10.1007/s40259-017-0256-z
https://doi.org/10.1007/s40259-017-0256-z
Autor:
Hanish Bagga, John Riordan, Paddy Hanrahan, Claire Barrett, Ray White, Mona Marabani, Peter K. K. Wong, Laurel Young, Peta Pentony, Doug Johnson, A. Katrib, Karin Leder
Publikováno v:
Internal Medicine Journal. 47:491-500
Autoimmune inflammatory rheumatic diseases (AIIRD), such as rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis are often complicated by infection, which results in significant morbidity and mortality. The increased risk of infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88a6a5cad573d55f67e3c145b4047fe0
https://doi.org/10.1111/imj.13371
https://doi.org/10.1111/imj.13371
Perceptions of Doppler ultrasound for rheumatoid arthritis disease activity assessment and education
Publikováno v:
International Journal of Rheumatic Diseases. 22:55-61
Aim The aim of this qualitative study was to report the findings of the Defining rheumatoid arthritis progression using Doppler Ultrasound in Clinical practice (DEDUCE) Medical Practice Activity, which was developed to facilitate the utilization of D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7754e2dc53a935407d2e02e6a75551ce
https://doi.org/10.1111/1756-185x.13034
https://doi.org/10.1111/1756-185x.13034
Autor:
Patrick Hanrahan, Geoffrey Chong, H. Miles Prince, Claire Barrett, Phillip Swarbrick, Peter K. K. Wong, John Riordan, Laurel Young, Hanish Bagga, Ray White, Mona Marabani, Teja Kodali
Publikováno v:
Current Rheumatology Reports. 20
Conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs) have been used in the treatment of inflammatory arthritis (IA) for many years. More recently, biologic (bDMARDs) and targeted synthetic (tsDMARDs) DMARDs have further improved t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c70d61bf1a5ebd605bdfd73d1528a03
https://doi.org/10.1007/s11926-018-0774-9
https://doi.org/10.1007/s11926-018-0774-9
Publikováno v:
Australian nursingmidwifery journal. 23(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eb9ce4869fba4e3bf4ff5ca717ca452d
https://pubmed.ncbi.nlm.nih.gov/26863712
https://pubmed.ncbi.nlm.nih.gov/26863712
Publikováno v:
Biochemical Society Transactions. 16:817-818
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db00c1aa17e468d95e1be1030956317f
https://doi.org/10.1042/bst0160817
https://doi.org/10.1042/bst0160817